Low-dose dexamethasone challenge in women with atypical major depression: pilot study

被引:0
|
作者
Levitan, RD
Vaccarino, FJ
Brown, GM
Kennedy, SH
机构
[1] Univ Toronto, Clarke Div, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada
来源
JOURNAL OF PSYCHIATRY & NEUROSCIENCE | 2002年 / 27卷 / 01期
关键词
corticotropin-releasing hormone; depression; atypical; dexamethasone; hormones; hydrocortisone; mood disorders; stress;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: To examine if atypical depression may be associated with hypersuppression of the hypothalamic-pituitary-ad renal (HPA) axis. Method: Eight women with atypical major depression and 11 controls with no history of psychiatric illness, matched on age and body mass index, were challenged with low-dose dexamethasone (0.25 mg and 0.50 mg in random order and 1 week apart). Dexamethasone was self administered at 11 pm, and plasma cortisol samples were drawn at 8 am and 3 pm on the following day. Results: After the 0.50-mg dexamethasone challenge, mean suppression of morning cortisol was significantly greater in patients with atypical depression (91.9%, standard deviation [SD] 6.8%) than in the controls (78.3%, SD 10.7%; p < 0.01). Conclusion: These preliminary data add to the growing body of literature that suggests atypical depression, in contrast to classic melancholia, may be associated with exaggerated negative feedback regulation of the HPA axis.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 50 条
  • [1] Combined low-dose physostigmine and AVP challenge in major depression
    Rubin, RT
    Sekula, LK
    OToole, S
    Czambel, RK
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 314 - 314
  • [2] MAJOR DEPRESSIVE EPISODE AND LOW-DOSE DEXAMETHASONE SUPPRESSION TEST
    SARAI, M
    TANIGUCHI, N
    KAGOMOTO, T
    KAMEDA, H
    UEMA, T
    HISHIKAWA, Y
    FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1982, 36 (02): : 109 - 114
  • [3] The DART study of low-dose dexamethasone therapy
    Rademaker, Karin J.
    Groenendaal, Floris
    van Bel, Frank
    de Vries, Linda S.
    Uiterwaal, Cuno S. P. M.
    PEDIATRICS, 2007, 120 (03) : 689 - 690
  • [4] Serial infusions of low-dose ketamine for major depression
    Rasmussen, Keith G.
    Lineberry, Timothy W.
    Galardy, Christine W.
    Kung, Simon
    Lapid, Maria I.
    Palmer, Brian A.
    Ritter, Matthew J.
    Schak, Kathryn M.
    Sola, Christopher L.
    Hanson, Allison J.
    Frye, Mark A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2013, 27 (05) : 444 - 450
  • [5] Serial Infusions of Low-dose Ketamine for Major Depression
    Frye, Mark
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 164S - 164S
  • [6] Lenalidomide Plus Low-Dose Dexamethasone Compared with Thalidomide Plus Low-Dose Dexamethasone: A Randomised Phase III Study
    Mookerjee, Anjali
    Gupta, Ritu
    Sharma, Atul
    Saikia, Tapan
    Kumar, Lalit
    BLOOD, 2011, 118 (21) : 1264 - 1265
  • [7] Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study
    Colunga-Pedraza, Perla R.
    De la Garza-Salazar, Fernando
    Vaquera-Alfaro, Hector A.
    Gomez-De Leon, Andres
    Bustillos-Munoz, Monica
    Tarin-Arzaga, Luz
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [8] The DART study of low-dose dexamethasone therapy - Reply
    Doyle, Lex W.
    Davis, Peter G.
    Morley, Colin J.
    McPhee, Andy
    Carlin, John B.
    PEDIATRICS, 2007, 120 (03) : 690 - 691
  • [9] Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial
    Smith, Deidre J.
    Sarris, Jerome
    Dowling, Nathan
    O'Connor, Manjula
    Ng, Chee H.
    NUTRITIONAL NEUROSCIENCE, 2018, 21 (03) : 224 - 228
  • [10] USE OF LOW-DOSE FLUOXETINE IN MAJOR DEPRESSION AND PANIC DISORDER
    LOUIE, AK
    LEWIS, TB
    LANNON, RA
    JOURNAL OF CLINICAL PSYCHIATRY, 1993, 54 (11) : 435 - 438